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SUMMARY 
Stimulation of the T3C12 clone of Friend erythroleukemia cells with 1.2% dimethyl sulfoxide 
(DMSO) results in progressive increase in the concentration of globin mRNA sequences in the total 
cellular RNA of treated cells, as measured by nucleic acid hybridization employing a globin cDNA 
probe. The greatest increment in the content of globin RNA occurs between 30 and 40 h after 
addition of DMSO. Globin cDNA was also used to measure the concentration of globin-specific 
sequences in the DNA and RNA of transcriptionally active and inactive chromatin fractions 
prepared from these cells by the DNase II - MgCl, procedure of Gottesfeld et al. [ 161. Essentially 
equal concentrations of globin sequences are present in the DNA isolated from active and inactive 
chromatin fractions of cells grown in the presence of 1.2 % DMSO for 50 h (the time of initiation of 
hemoglobin synthesis). Furthermore, there are no significant differences in the globin gene con- 
centrations between the active chromatin fractions from DMSO-treated and control cultures at 
either 50 or 120 h after initiation of DMSO treatment. However, chromatin-associated RNA 
isolated from the active chromatin of cells synthesizing maximum amounts of hemoglobin (120 h) 
contains a higher concentration of globin sequences than RNA from the active chromatin of 
control cells. Chromatin fractions from untreated cells also contain a significant amount of RNA 
which hybridizes to the globin cDNA probe. These observations suggest that both transcriptional 
and post-transcriptional control mechanisms are involved in hemoglobin gene expression in T3C12 
erythroleukemia cells. 
Only a minor portion of the total nuclear 
DNA of differentiated cells in a mammalian 
organism is transcribed [l]. Restriction of 
transcription of nuclear DNA has been im- 
plicated as a major mechanism by which 
eukaryotic cells regulate gene expression 
during development [2-51. In order to 
further elucidate possible transcriptional 
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mechanisms of specific gene expression, 
several methods have been developed for 
the preparation of chromatin fractions ac- 
tively engaged in transcription. Transcrip- 
tional activities of isolated chromatin frac- 
tions are frequently defined by (1) the pres- 
ence of nascent RNA chains [6-93; (2) endo- 
genous RNA polymerase activity [7, 10, 
111; (3) the preferential binding to [ 121 or 
transcription of [7-9, 12, 131 chromatin by 
E. coli RNA polymerase. The studies of 
Howk et al. [ 141, utilizing the Moloney type 
“C” proviral DNA sequence in infected 
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3T3 cells, and Rickwood et al. [15], using 
the globin gene in the 707 clone of mm-me 
erythroleukemia cells, have examined the 
possibility of enrichment of specific gene 
sequences in “active” chromatin isolated 
by three different chromatin fractionation 
schemes. In both reports, the results indi- 
cated that although the genes under inves- 
tigation were transcribed in vivo, they were 
not preferentially segregated into the iso- 
lated “active” chromatin fractions. Instead, 
nearly equal concentrations of the active 
gene sequences were found in “active” and 
“inactive” chromatin. 
The fractionation scheme devised by 
Gottesfeld et al. [16, 171 has provided an 
additional way to prepare transcriptionally 
active chromatin fractions. In this method, 
chromatin is first sheared by limited diges- 
tion with DNase II. Inactive chromatin is 
separated by centrifugation and precipita- 
tion with 2 mM MgC&. The soluble active 
chromatin fraction has been shown to con- 
sist of tissue-specific subsets of middle and 
non-repetitive DNA sequences [16, 171. In 
addition, the non-repetitive class of DNA 
from the putative active fraction appears 
to be enriched in sequences coding for cel- 
lular RNA [16]. After extensive DNase II 
digestion, both transcriptionally active and 
inactive chromatin contain “subunits” of 
nucleoprotein. The nuclease resistant struc- 
tures of inactive chromatin are DNA-his- 
tone complexes resembling v bodies; how- 
ever, those from active chromatin are com- 
plexes of DNA, RNA, histone, and non- 
histone proteins [ 181. 
A preferential digestion of active chroma- 
tin segments has also been observed with 
DNase I. Weintraub & Groudine [19] have 
shown that the active globin gene of ery- 
throcyte nuclei, but not the inactive oval- 
bumin gene, is preferentially digested by 
DNase I. Similar results have been obtained 
for the transcriptionally active ovalbumin 
gene from chick oviduct nuclei [20]. 
In this study we have employed the 
T3C12 clone of murine erythroleukemia 
cells, which accumulate globin mRNA after 
stimulation by dimethyl sulfoxide (DMSO), 
to determine whether changes in the con- 
tent of globin gene sequences could be de- 
tected in the “active” chromatin fraction of 
DMSO-treated cells. 
MATERIALS AND METHODS 
Growth of cells 
The T3C12 clone of murine erythroleukemia cells, 
originally isolated by Ikawa et ai. [21], was obtained 
from the National Institutes of Health through the 
courtesy of Dr Philip Leder. Cells were grown and 
stimulated as previously described [22]. Synthesis of 
hemoglobin in the cultures was determined by benzi- 
dine stamina 1231. Addition of 1.2 % DMSO to cultures 
of T3C12 c& resulted in the accumulation of hemo- 
globin beginning 50 h after exposure to the inducer. 
By 120 h greater than 90% of the treated cells con- 
tained hemoglobin, but only l-2% of the untreated 
control cells were benzidine positive. 
Preparation of nucleic acids from 
chromatin fractions 
Chromatin was prepared from control and treated cells 
by a modification [22] of the procedure of Huang & 
Huang [24]. Purified chromatin was fractionated as 
described by Gottesfeld et al. [16]. Chromatin pellets 
P1 and PZ represented inactive fractions, whereas the 
S, supematant contained actively transcribed chroma- 
tin segments [ 16, 221. 
Total nucleic acids were prepared from these chro- 
matin fractions bv the followina nrocedures. Chroma- 
tin pellets were resuspended &-STE buffer (0.02 M 
Tris-HCl (DH 7.4). 0.1 M NaCl. 0.001 M EDTA). 
Sodium ddhecyl sulfate (SDS) and self-digested Pro- 
nase (nuclease-free, Calbiochem) were added to attain 
0.5 % and 500 @g/PI, respectively. After a 30 min 
incubation at 37°C the samples were extracted three 
times with equal volumes of STE-saturated phenol. 
The final aqueous phases were precipitated overnight 
at -20°C with 2 vol of ethanol. DNA was DreDaRd 
from total nucleic acid preparations of cells giov&r for 
50 or 120 h with or without DMSO by adjusting the 
samples to 0.3 N NaOH and heating at 100°C for 30 
min. This procedure also shears the DNA to 200-300 
nucleotides in length [25]. After neutralization the 
DNA was recovered by ethanol precipitation. 
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Chromatin-associated RNA was also isolated from 
the various chromatin fractions of cells grown for 120 
h. In this case, a portion of the total nucleic acid 
preparation was redissolved in 0.02 M Tris-HCI (pH 
7.4), 0.01 M M&I, to a concentration <I ma/ml. 
DNA was digested with 20 pg/ml of RNase-free DBase 
I [26] at room temperature for 2 h followed by phenol 
extraction and ethanol precipitation. This DNase I 
digestion process was repeated once to insure com- 
plete removal of DNA. 
Isolation of total cellular RNA 
In order to examine the synthesis of globin mRNA, 
control and 1.2 % DMSO-treated cells were grown for 
20, 30, 40, 60, and 90 h as described [22]. Total 
celhdar RNA was isolated from these cells by proce- 
dures described above: Pronase digestion, phenol ex- 
traction, DNase I digestion, and re-extraction with 
phenol. 
Globin cDNA synthesis 
Globin mRNA was isolated from mouse reticulocyte 
polysomal RNA by column chromatography on oligo- 
fd??-cellulose r271 followed bv sucrose nradient cen- 
trifugation. The 95 globin mRNA was homogenous on 
2 % acrylamide, 0.5 % agarose gels [28] and coded only 
for a- and j9-globin peptide chains in a wheat germ 
cell-free orotein svnthesizina svstem r29i. 
DNA complementary to mouse globin mRNA (glo- 
bin cDNA) was synthesized essentially as described by 
Sullivan et al. [30]. The 0.5 ml reaction mixture con- 
sisted of the following: 0.06 M Tris-HCl (pH 8.1), 
0.008 M MgQ, 1 x 1O-4 M each of dCTP and dTTP, 
500 &i/ml each of rH]dGTP (3.6~10~~ M) and 
[3H]dATP (4.2~ 10m5 M), 0.028 M fl-mercaptoethanol, 
1 pgglml oligo(dTh2--1s, 100 pg/rnl actinomycin D, 
6.7 pg/ml mouse globin mRNA, and 5 U/ml avian 
myeloblastosis virus reverse transcriptase (Dr J. W. 
Beard. Lie Sciences, Inc.). Bentonite (32 &ml) was 
also added to inhibit any residual RN&e activity 
present in the reverse transcriptase preparations [31]. 
After a 16 h incubation at 37”C, the sample was 
digested with Pronase, phenol-extracted, and precipi- 
tated with ethanol as described above. The de-pro- 
teinized nucleic acids were dissolved in 100 ~1 of 0.02 
M Tris-HCl (pH 7.4). 0.01 M EDTA and digested with 
RNase (50 pg/ml) at 37°C for 1 h. The DNA was 
then phenol-extracted and ethanol-precipitated over- 
night. Single-strand DNA was separated from duplex 
DNA on hydroxyapatite [32], desalted by Sephadex 
G-50 chromatography, and precipitated in ethanol. A 
total of 1.4~ 10s cpm of single-stranded DNA with a 
specific activity of 16000 cpmlng was obtained. Only 
7 % of the DNA prepared in this manner was resistant 
to digestion by the single-strand-specific S, nuclease, 
and it was 4-6s in size on alkaline sucrose gradients. 
Results of hybridization of this cDNA probe to mouse 
globin mRNA are presented in fig. 1. Hybrid formation 
was first detected at a C, t value of approx. 5 X lo+ 
and was essentially completed at a C,t of 1X lo-*. 
Therefore, it is likely that the cDNA preparation 
consists of only two classes of molecules (a- and 
g-globin cDNA) which are present in equal amounts 
and reflect the 1: 1 ratio of o- and &obin mRNA 
in mouse reticulocvte nolvsomes r331. The C, tr (vdue 
at which 50% hybridization is achieved) of 2; 10-s 
is nearly identical with the value of 1.7~ 10m3 obtained 
by Gielen et al. [34] for the hybridization of rabbit 
globin mRNA to its cDNA product. 
Nucleic acid hybridization 
All alobin cDNA : RNA hvbridizations were oer- 
formed in 50 ~1 volumes containing 0.6 M NaCl, 6.04 
M Tris-HCl (pH 7.4), 0.002 M EDTA, approx. 1000 
cpm of globin cDNA, and variable amounts of sample 
RNA diluted with 2 ma/ml veast RNA. The veast 
RNA was employed to reduce the effects of residual 
ribonuclease activity. Mixtures were overlaid with 
mineral oil and incubated at 68°C for 24 h. Globin 
cDNA : chromatin DNA hvbridizations were con- 
ducted in 30 ~1 volumes which contained: 0.02 M Tris- 
HCl (nH 7.4). 0.01 M EDTA. 0.6 M NaCl. 2600 cam 
glob& cDNA, and variable ‘amounts of test DNA 
Samples were overlaid with mineral oil and incubated 
at 68°C for 50 or 100 h. The extent of hybridization 
of each sample was determined by single-strand- 
specific S, nuclease [35] prepared from Sanzyme-R 
{F;lbiochem) by chromatography on DEAE-cellulose 
RESULTS 
Accumulation of globin mRNA in T3C12 
erythroleukemia cells treated with DMSO 
Accumulation of globin mRNA in DMSO- 
treated T3C12 cells was measured by nu- 
cleic acid hybridization between a DNA 
probe complementary to globin mRNA 
(cDNA) and total cellular RNA isolated 
from cells grown for varying periods of 
time. The data in fig. 2 indicate a time- 
dependent increase in globin RNA concen- 
tration, as evidenced by the progressive 
decrease in C, tt values of the RNA prep- 
arations from treated cells. The largest in- 
crement in globin mRNA concentration (lo- 
fold) was seen between 3040 h after stimu- 
lation with DMSO. This increase occurred 
immediately prior to hemoglobin synthesis 
in these cells. Unstimulated cell samples, 
on the other hand, did not show progressive 
increase in concentration of globin mRNA 
(data not shown). 
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Fig. 1. Abscissa: C,t values; ordinate: % hybridiza- 
tion. O-O, Crt*=2.00X lo+. 
Hybridization of globin cDNA to mouse globin 
mRNA. Mouse globin mRNA was isolated as de- 
scribed in the “Materials and Methods”. Hybridiza- 
tions were performed in 50 ~1 with 0.6 M NaCl, 
1000 cpm of globin cDNA, and variable amounts of 
globin mRNA to achieve the desired C, t values. 
Samples were allowed to anneal at 68°C for 24 h. 
Hybrid formation was determined using single-strand- 
specific S, nuclease. Data were corrected for the 7% 
self-annealing of the globin cDNA. 
of hemoglobin synthesis) and 120 h (the 
time of maximum hemoglobin synthesis). 
The active and inactive chromatin from 
cells grown without DMSO for 50 h ap- 
peared to contain nearly identical concen- 
trations of the globin gene. As shown in 
fig. 3, the C, ti values for the P1 (inactive) 
and S, (active) DNA were 9~ lo3 and 11 X 
103, respectively. Similar data were ob- 
tained for cells grown 50 h in the presence 
of DMSO. Furthermore, no increase (com- 
pared with control) in the globin gene con- 
centration of the S, fraction from treated 
cells was evident. Chromatin fractions iso- 
lated from cells grown for 120 h provided 
essentially the same results (data not 
shown), in that the globin gene concentra- 
tions of the control and treated active frac- 
tions were virtually identical with apparent 
C, tg values of 2.3 x lo4 and 3.5 x 104, respec- 
tively. 
Analysis of “active” and “inactive” 
chromatin fractions for the presence of 
the globin gene 
Transcriptional activities of chromatin frac- 
tions isolated by the DNase II - MgClz tech- 
niques of Gottesfeld et al. [16] from T3C12 
cells were estimated by the incorporation of 
radioactive uridine into rapidly-labeled 
chromatin-associated RNA [22]. These re- 
sults indicated that the active chromatin 
fractions (S2) of both control and treated 
cells had specific activities ([3H]uridine 
cpm/pg DNA) 7-14-fold greater than the in- 
active (P1 and PJ fractions. In addition, 
approx. 50% of the total incorporated uri- 
dine counts were found in the active frac- 
tion, which contained only 5% of the total 
chromatin DNA [22]. 
Globin-specific nucleotide sequences 
in chromatin-associated RNA 
RNA associated with the chromatin frac- 
tions of control and treated cells grown for 
The concentration of globin gene se- 
quences was examined in actively- and 
inactively-transcribed chromatin fractions 
from control and DMSO-induced cells 
grown for 50 h (the apparent time of onset 
100 10' 102 103 104 105 
Fig. 2. Abscissa: C,t values; ordinate: % hybridiza- 
tion. 
Hybridization of globin cDNA to total cellular RNA 
from 1.2 % DMSO-treated cells. Cells were stimulated 
for A-A, 20 h; O---O, 30 h; CD, 40 h; O---O, 
60 h: and CO, 90 h. Total cellular RNA was iso- 
lated as described in the “Materials and Methods”. 
Hybridizations were performed as indicated in fig. 1. 
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Table 1. Hybridization of globin cDNA to 
chromatin-associated RNA from control 
and I .2 % DMSO-treated T3C12 cells 
RNA was extracted from chromatin fractions of cells 
grown for 120 h after 2 cycles of DNase I digestion 
as described under “Materials and Methods”. RNA 
was hybridized to globin cDNA as outlined in fig. 1. 
Each hybridization value represents the mean of two 
independent determinations of the same RNA prep- 
aration (average variation from the mean ~10%). UC 
represents unfractionated chromatin, P, and P2 inac- 
tive chromatin, and S, active chromatin 
Fig. 3. Abscissa: C,t values; ordinate: % hybridiza- 
tion. 
Hybridization of globin cDNA to DNA of chromatin 
fractions isolated from control and 1.2% DMSO- 
treated T3C12 cells. DNA of chromatin fractions iso- 
lated from (a) control or (b) treated cells grown for 
50 h. O---O, Unfractionated chromatin; A-A, P,; 
0.. ‘0, PI; and U, SZ. Hybridizations were per- 
formed as described in tig. 1 in 30 ~1 with 2600 cpm 
of globin cDNA and varying amounts of DNA. Sam- 
ples were allowed to anneal at 68°C for 50 or 100 h. 
120 h was examined for its concentration of 
globin RNA sequences at 2 C, t values. The 
data in table 1 indicate that all fractions con- 
tained material that was complementary to 
the cDNA probe. The unfractionated, P1, 
and S, chromatin of the control group con- 
tained globin sequences which were de- 
tectable at a C, t of 7.5~ 102. RNA from 
the control P2 fraction had the lowest con- 
centration of globin sequences. The hy- 
bridization values for all four treated chro- 
matin fractions were greater than the con- 
trols at both C,t values. The treated Sz 
fraction contained the greatest concentra- 
tion of globin RNA sequences. In order to 
eliminate the possibility that the hybridiza- 
tion observed with the RNA isolated from 
% Hvbridization 



















treated cell chromatin was due to cyto- 
plasmic globin mRNA, potential contami- 
nation of treated cell chromatin fractions 
was estimated by the addition of [3H]~ri- 
dine-labeled T3C12 cytoplasmic RNA to 
the total cell homogenate of a DMSO- 
induced culture. Chromatin fractions were 
isolated, and the radioactivity associated 
with each fraction was determined. Less 
than 0.27-0.33% of the recovered radio- 
activity was associated with the DMSO- 
treated cell chromatin fractions in these ex- 
periments. The expected hybridization due 
to possible contaminating cytoplasmic glo- 
bin mRNA was calculated using the follow- 
ing parameters: (1) the % contamination 
by 3H-labeled cytoplasmic RNA (0.27- 
0.33%); (2) specific activity of the labeled 
cytoplasmic RNA; (3) the fraction of the 
cytoplasmic RNA which is globin mRNA 
(0.02% from Ross et al., [S]); and (4) hy- 
bridization values obtained from fig. 1. For 
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the treated S, chromatin RNA, for example, 
it was calculated that the extent of con- 
tamination (0.27% of the recovered radio- 
activity) could only account for about 2% 
of the observed hybridization at a C, r value 
of 7.5~ lo2 (table 1). A lo-fold underestima- 
tion of the concentration of cytoplasmic 
globin mRNA would increase the 2% hy- 
bridization value to 20%, still less than 
l/4 of the actual observed value. 
DISCUSSION 
The chromatin fractionation procedure of 
Gottesfeld et al. [ 161 was utilized to study 
a cell line in which transcriptional control 
appears to be of primary importance in the 
accumulation of globin mRNA. One of the 
purposes was to determine if a detectable 
shift occurs in the structural configuration 
of the globin gene in erythroleukemia cells 
induced to synthesize hemoglobin by the 
addition of DMSO. From our results this 
does not appear to be the case. Examina- 
tion of the active (S2) and inactive (P, and 
P2) chromatin fractions from control and 
treated T3C12 cells indicates no major dif- 
ferences in the concentration of the globin 
gene (fig. 3). 
The reasons for the lack of a distinct 
segregation of globin gene sequences be- 
tween transcriptionally active and inactive 
chromatin may relate to one or,more of the 
following points. (1) The apparent synthesis 
of globin RNA in unstimulated T3C12 cells 
(table l), suggests the existence of post- 
transcriptional control mechanisms. The 
globin gene appears to be transcribed in 
control cells without translation of the glo- 
bin mRNA. Under such circumstances, the 
globin gene concentration in the active 
chromatin of DMSO-stimulated cells might 
be expected to be similar to that in the 
controls. Rickwood et al. [ 151 also report 
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no segregation of the globin gene in the 
active chromatin fraction (isolated on 
metrizamide gradients) in the 707 clone 
of erythroleukemia cells, in which post- 
transcriptional control mechanisms are 
known to be operative [37, 381. (2) Wein- 
traub & Groudine [19] have reported that 
the globin gene in mature chick erythro- 
cytes is in a conformation which is suscep- 
tible to DNase I digestion. Interestingly, 
this susceptibility is not necessarily due to 
the actual transcription of the gene since 
the globin gene in mature erythrocytes, 
which are not transcribing globin mRNA, 
is still digested by DNase I. It is conceiv- 
able that a configuration which is sensitive 
to DNase I is established for those genes 
normally transcribed during the develop- 
ment of a particular cell type irrespective of 
whether they are actually being transcribed 
at the time. This may be the case for 
T3C12 cells which appear to be arrested at 
some early stage in erythroid differentia- 
tion. It is possible that at this stage a 
DNase sensitive configuration already 
exists for the globin genes which are only 
minimally transcribed until the proper stim- 
ulus (e.g. DMSO) is encountered. DNase 
II used in this chromatin fractionation pro- 
cedure may recognize this configuration to 
an equivalent extent in both control and 
treated cells, resulting in equal concentra- 
tions of the globin gene in the active frac- 
tion from both types of cells. Finally, lack 
of a differential distribution of the globin 
gene between the active and inactive chro- 
matin of control and treated cells may also 
reflect an incomplete separation of actively- 
transcribed DNA sequences from the in- 
active chromatin fraction by the DNase II 
method. 
The globin cDNA probe was also used to 
examine the concentration of globin RNA 
sequences in total cellular RNA and in 
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chromatin-associated RNA from DMSO- been thought that the induction of globin 
stimulated cells. It was found that the RNA and hemoglobin synthesis was due 
globin RNA concentration increases as 
early as 30 h after DMSO addition (fig. 2); 
however, the largest increment occurs be- 
tween 30 and 40 h, well before hemoglobin 
is first detected (50-60 h) by the benzidine 
stain. Comparison of the 20 and 90 h C, tt 
values indicates that there is an overall 
400-fold increase (4x lo311 x 10’) in the con- 
centration of globin RNA in these cells. 
Using the mouse globin mRNA as a stan- 
dard (fig. l), it is calculated that the total 
RNA of cells stimulated for 90 h contains 
0.02% globin sequences. This is in accord 
with the value obtained by Ross et al. [5] 
for DMSO-treated T3C12 cells. The con- 
centration of globin mRNA in the mouse 
reticulocyte is 2.8% of the total cellular 
RNA [5]. Thus, the reticulocyte contains 
over 100 times the concentration of globin 
mRNA present in the 90 h-induced T3C12 
cell. This is not surprising since the T3C12 
cell would be expected to contain a wider 
variety of mRNA than does the reticulo- 
cyte. 
Previously reported results indicate that 
the active (S,) chromatin fractions from 
both control and treated T3C12 cells con- 
tain the highest specific activities of rapidly- 
labeled nuclear RNA [22]. Using the globin 
cDNA probe to measure the concentration 
of globin RNA sequences in chromatin- 
associated RNA (table l), it was found that 
the treated cell chromatin fractions contain 
higher concentrations of globin RNA and 
that the active (S,) fraction from treated 
cells has the greatest concentration. Berko- 
witz & Doty [9] have also reported that ac- 
tive chromatin of chicken reticulocytes, ob- 
primarily to a change in gene transcription 
[5, 39, 401. Thus, the hybridization ob- 
served between globin cDNA and RNA 
obtained from control cell chromatin frac- 
tions was unexpected. Although unstimu- 
lated cultures exhibit a low basal level of 
differentiation (l-2 % of the cells are ben- 
zidine-positive at 120 h), it is unlikely that 
this would account for the 40-50% hybrid- 
ization observed at a C, t of 7.5~ 102. This 
result implies a role for post-transcriptional 
mechanisms in the control of globin gene 
expression in T3C12 cells, as has been 
suggested by Paul and his colleagues for the 
707 clone of erythroleukemia cells [37, 381. 
Post-transcriptional control mechanisms 
may be exerted during nuclear processing, 
transport to the cytoplasm, or translation 
of mRNA. A rigorous examination of the 
concentration of globin RNA in chromatin, 
nuclear, polysomal, and “soluble” fractions 
of these cells is necessary to settle this 
issue. 
In summary, the induction of hemoglobin 
synthesis in T3C12 erythroleukemia cells 
most likely results from changes in both 
transcriptional and post-transcriptional 
events which do not appear to coincide with 
a change in the structural arrangement of 
the globin gene as detected by DNase II 
sensitivity. 
A preliminary report of this data was presented at 
the annual meeting of the American Association for 
Cancer Research, Mav 4-8. 1976. 
Dual-isotope data were calculated with the help of 
the University of Michigan Medical School Fund for 
computing. This work was supported by the NIH 
grant CA-12765 and by the University of Michi- 
gan, Department of Pharmacology Training Grant 
NIGMS 198-18. 
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